Asthma, accompanied by lung inflammation, bronchoconstriction and airway hyper-responsiveness, is a significant public health burden. Here we report that Mas-related G proteincoupled receptors (Mrgprs) are expressed in a subset of vagal sensory neurons innervating the airway and mediates cholinergic bronchoconstriction and airway hyper-responsiveness. These findings provide insights into the neural mechanisms underlying the pathogenesis of asthma.
1
. Emerging evidence suggest that sensory nerves in the airway play an important role in the pathogenesis of asthma [2] [3] [4] [5] . MrgprC11, a previously identified itch receptor, is expressed in dorsal root ganglion (DRG) sensory neurons innervating the skin and mediates nonhistaminergic itch 6, 7 . We found that MrgprC11 is specifically expressed in vagal ganglia, outside the DRG ( Supplementary Fig. 1a ). Vagal ganglia consist of two different ganglia, termed nodose and jugular ganglia, with distinct embryonic origins: nodose neurons are derived from the epibranchial placode, while jugular neurons are derived from the neural crest 8 . Using Wnt1-Cre;R26-lsl-LacZ mice, in which all neural crest-derived neurons express LacZ, we found that MrgprC11 is selectively expressed in jugular sensory neurons, but not in nodose sensory neurons (Fig. 1a-c and Supplementary Figs. 1c-e and 2). Notably, hMrgprX1, the functional ortholog of MrgprC11, is also selectively expressed in jugular ganglion ( Supplementary Fig. 1b) .
MrgprC11 immunoreactivity was detected in 6.15% (84 of 1,365) of jugular sensory neurons and in 2.00% (84 of 4,190) of total vagal sensory neurons. MrgprC11
+ jugular sensory neurons were of small diameter (average: 200.27 ± 9.24 μ m 2 ), positive for nociceptor marker TRPV1 (Fig. 1d-f ) and negative for myelinated neuron marker neurofilament 200kD ( Supplementary Fig. 3 ). We performed retrograde tracing to determine whether MrgprC11 + jugular sensory neurons innervate the airway. We observed a total of 750 airway-innervating vagal sensory neurons labeled by retrograde tracer CTB-488 (cholera toxin B subunit conjugated with Alexa Fluor-488) and found that 64 of them were MrgprC11 + ( Fig. 1g-i 
), demonstrating that MrgprC11
+ jugular neurons innervate the airway. However, none of the 201 airway-innervating DRG neurons were MrgprC11 + ( Fig. 1j-l) . Therefore, we concluded that MrgprC11 + primary sensory neurons in different sensory ganglia exhibit different peripheral innervation patterns: MrgprC11
+ jugular sensory neurons innervate the airway, whereas MrgprC11
+ DRG sensory neurons innervate the skin (Fig. 1m ) 7, 9 . These results allow us to attribute the physiological responses in the airway induced by the activation of MrgprC11 to jugular sensory neurons in the following experiments.
Bam8-22, a specific peptide agonist for MrgprC11 7 , can effectively excite MrgprC11
+ jugular sensory neurons in both calcium imaging assay and whole-cell patch-clamp recordings (Supplementary Fig. 4a- 
d). The vagal sensory neurons isolated from Mrgpr-clusterΔ
−/− mice, in which 12 Mrgpr-encoding sequences including MrgprC11 were deleted 7 , failed to respond to Bam8-22 ( Supplementary Fig. 4a ). Among the 12 mouse Mrgpr genes, MrgprC11 is the only receptor that can respond to Bam8-22 in a heterologous system ( Supplementary Fig. 5a ,b) and mediate Bam8-22-induced responses in the vagal sensory neurons ( Supplementary Fig. 4e,f) . To determine whether Bam8-22 can activate airway-innervating vagal sensory neurons, we performed ex vivo GCaMP imaging of vagal ganglia ( Supplementary Fig. 6 ) using Pirt-Cre;R26-GCaMP6 mice, in which the pan-sensoryneuron Pirt promoter drives the expression of GCaMP6 in > 95% of sensory neurons 10 . Administration of Bam8-22 onto the airway induced robust Ca 2+ increase in 2.67% (33 of 1,237 cells from 10 mice) of vagal sensory neurons ( Supplementary Fig. 6b,c) , suggesting that Bam8-22 activated a subset of jugular sensory neurons innervating the airway.
To elucidate the function of MrgprC11 + jugular sensory nerves in the airway, we performed head-out, whole-body plethysmography. Aspiration of Bam8-22 into the airway evoked a change in the respiratory pattern, characterized by an increase in the amplitude of the respiratory waveform and a slight but significant increase in the respiratory rate (Fig. 1n-p and Supplementary Fig. 7a-c ). In contrast, Bam8-22 did not induce any change in respiration in MrgprclusterΔ −/− mice (Fig. 1o,p and Supplementary Fig. 7a-c) . The Bam8-22-induced respiratory effect was similar to that observed upon the administration of methacholine, a bronchoconstrictor Mrgprs on vagal sensory neurons contribute to bronchoconstriction and airway hyperresponsiveness acting on muscarinic acetylcholine receptor (mAChR) in airway smooth muscle (Fig. 1n ,q,r and Supplementary Fig. 7d,e) . Both Bam8-22-and methacholine-induced respiratory effects were blocked by ipratropium bromide, a mAChR blocker (Fig. 1q,r and Supplementary Fig. 7d,e) . Administration of capsaicin to activate TRPV1 + vagal sensory neurons induced a different respiratory response, characterized by a cessation in breathing that persisted for an average of 5.66 ± 0.81 s, followed by a secondary phase with diminished frequency and prolonged braking after each breath (Fig. 1n ). This is a prototypical response induced by the administration of respiratory sensory irritants such as cigarette smoke and cinnamaldehyde into the respiratory tract [11] [12] [13] [14] . We note that although
MrgprC11
+ jugular sensory neurons express TRPV1, the respiratory reflexes evoked by Bam8-22 and capsaicin are quite different. These results suggest that activation of a few afferents by Bam8-22 versus activation of a large population by capsaicin can produce nonlinear effects in lung responses.
The similarity between Bam8-22-induced and methacholineinduced respiratory responses led us to hypothesize that Bam8-22 may induce bronchoconstriction, which we tested by measuring airway mechanics. Retro-orbital intravenous injection of Bam8-22 significantly increased lung resistance in wild-type (WT) mice but not in Mrgpr-clusterΔ −/− mice ( Fig. 2b and Supplementary Fig. 8a,b) , demonstrating that Bam8-22 induces bronchoconstriction. Stimulation + jugular sensory neurons innervate the lung, whereas MrgprC11 + DRG sensory neurons innervate the skin. n, Representative traces of pulmonary airflow waveforms from WT and Mrgpr-clusterΔ −/− mice at baseline and 1 min (peak time) after intratracheal instillation of 2 μ L Bam8-22 (10 mg/mL), methacholine (MCh; 0.2 mg/mL) and capsaicin (0.3 mg/mL). o,p, Bam8-22 evoked an increase in the amplitude of the respiratory waveform (o) and an increase in the respiratory rate (p) in WT mice, but not in Mrgpr-clusterΔ −/− (KO) mice (WT + saline, n = 9; WT + Bam8-22, n = 11; KO + saline, n = 7; KO + Bam8-22, n = 8; for o: WT + saline vs. WT + Bam8-22, P = 0.0022; WT + Bam8-22 vs. KO + Bam8-22, P = 0.029; for p: WT + saline vs. WT + Bam8-22, P = 0.0003; WT + Bam8-22 vs. KO + Bam8-22, P = 0.0038). q,r, Bam8-22-induced respiratory effect was similar to that observed upon the administration of methacholine, a bronchoconstrictor. Ipratropium bromide (ipra), a cholinergic blocker, inhibited the increase in amplitude of the respiratory waveform induced by Bam8-22 (q) but did not inhibit the increase in the respiratory rate (r). All methacholineinduced respiratory effects were blocked by ipratropium bromide (naive + saline, n = 6; ipra + saline, n = 7; naive + MCh, n = 7; ipra + MCh, n = 8; naive + Bam8-22, n = 8; ipra + Bam8-22, n = 8; for q: naive + MCh vs. ipra + MCh, P = 0.0003; naive + Bam8-22 vs. ipra + Bam8-22, P = 0.0001; for r: naive + MCh vs. ipra + MCh, P = 0.039; naive + Bam8-22 vs. ipra + Bam8-22, P = 0.509). All immunostaining, retrograde tracing and plethysmograph experiments were repeated independently three times each with similar results. Scale bars, 50 μ m. ***P < 0.005, **P < 0.01, *P < 0.05; n.s., not significant; two-tailed unpaired Student's t test. Data are presented as mean ± s.e.m.
of a subset of vagal sensory neurons causes release of acetylcholine from parasympathetic nerve fibers, which in turn acts on the mAChR in airway smooth muscle to induce bronchoconstriction ( Fig. 2a) 
15
. This parasympathetic cholinergic pathway is the major neural mechanism controlling bronchoconstriction in the lung 15 . The Bam8-22-induced increase in lung resistance was completely blocked by ipratropium bromide (Fig. 2c ) and vagotomy surgery (Fig. 2d) , which severs the vagus nerve, demonstrating that Bam8-22 induced cholinergic bronchoconstriction. Bam8-22-induced bronchoconstriction was not affected by the deletion of TRPA1 or TRPV1 ( Supplementary Fig. 8c ). Bam8-22 did not cause tracheal smooth muscle contraction (Fig. 2e) , ruling out the possibility that Bam8-22 directly stimulates airway smooth muscle. Taken together, these data suggest that Bam8-22 activates MrgprC11 + jugular sensory neurons, which in turn stimulate the parasympathetic system and induce cholinergic bronchoconstriction.
We also observed similar Bam8-22-induced effects in guinea pigs, another species frequently used to study respiratory reflex and to model respiratory diseases. gpMrgprx1 (clone XM_003462608), the predicted Mrgprc11 ortholog, is expressed in airway-innervating jugular and nodose neurons ( Supplementary  Fig. 9a,b) . Bam8-22 activated guinea pig vagal sensory neurons in a gpMrgprx1-dependent way ( Supplementary Fig. 9c-e) . Notably, intravenous injection of Bam8-22 in guinea pigs induced robust bronchoconstriction ( Fig. 2f and Supplementary Fig. 9f ). However, whether Bam8-22 also activates a vagal-cholinergic reflex to induce bronchoconstriction in guinea pigs, as it does in mice, requires further investigation.
Anaphylaxis is an acute, potentially life-threatening allergic reaction mediated by mast cell activation. Anaphylactic symptoms in the respiratory system include coughing, airway swelling and bronchoconstriction 16 . Retro-orbital injection of ovalbumin (OVA) resulted in a pronounced increase in lung resistance in OVAsensitized WT mice (Fig. 3a) . This effect was significantly inhibited in sensitized Mrgpr-clusterΔ −/− mice ( Fig. 3a and Supplementary  Fig. 8d ), suggesting that Mrgprs mediate anaphylactic bronchoconstriction. Anaphylactic bronchoconstriction is evoked mainly by mast cell mediators acting on both airway smooth muscle and sensory nerves 17 . Notably, neuropeptide FF, an MrgprC11 agonist that can be released by activated mouse bone marrowderived mast cells 18 , also induced bronchoconstriction ( Fig. 3b and Supplementary Fig. 8e ). Additional studies are required to determine whether Mrgprs play a role in the sensitization of mast cells, their activation or both. + DRG sensory neurons, respectively, did not induce bronchoconstriction, consistent with the fact that MrgprC11
+ DRG sensory neurons do not innervate the airway (WT i.v., n = 8; KO i.v., n = 7; WT reversed, n = 6; WT subQ, n = 6; WT i.t., n = 6; WT i.v. baseline vs. Bam8-22, P = 5.36 × 10 -5 ). c, Bam8-22-induced bronchoconstriction was blocked by cholinergic blocker ipratropium bromide (naive, n = 6; ipra, n = 5; P = 0.00085). d, Bam8-22-induced bronchoconstriction was blocked by vagotomy (sham, n = 7; vagotomy, n = 7; P = 0.004). e, Representative trace of airway smooth muscle contraction in response to electrical field stimulation and Bam8-22. Influenza virus infection causes characteristic effects within the respiratory tract, including airway inflammation and airway hyper-responsiveness. It is a major risk factor for exacerbation of asthma and causes significant morbidity and mortality annually 19 . We infected WT and Mrgpr-clusterΔ −/− mice with influenza A virus (IAV) to examine whether sensory nerves contribute to IAV-induced respiratory symptoms. Both WT and Mrgpr-clusterΔ −/− mice displayed robust immune responses after inoculation ( Fig. 3d and Supplementary Fig. 10a,b) . However, we observed significantly lower IAV-induced airway hyper-responsiveness in Mrgpr-clusterΔ −/− mice compared to WT mice (Fig. 3c) , demonstrating that Mrgprs are required for IAV-induced airway hyper-responsiveness. The deletion of Mrgpr genes did not affect the airway hyper-responsiveness in a dust mite-induced allergic asthma model ( Supplementary  Fig. 11 ). These data suggest that distinct mechanisms exist for the development of airway hyper-responsiveness under different pathological conditions.
We next asked whether direct stimulation of MrgprC11 + jugular sensory neurons could induce airway hyper-responsiveness in the absence of lung inflammation. We pretreated WT and MrgprclusterΔ −/− mice with Bam8-22 to activate MrgprC11 + jugular sensory neurons. Five minutes after Bam8-22 treatment, when the airway resistance had returned to its baseline level, airway responsiveness to methacholine were measured in WT and MrgprclusterΔ −/− mice. We found that pretreatment with Bam8-22 caused a remarkable increase in airway responsiveness in WT mice, but not in Mrgpr-clusterΔ −/− mice (Fig. 3e) . As expected, the enhanced airway sensitivity was abolished by vagotomy in WT mice (Fig. 3f ). These data demonstrate that activation of MrgprC11 + jugular sensory neurons can potentiate airway responsiveness in the absence of inflammation. Airway responsiveness to methacholine is the result of both direct action on airway smooth muscle and muscle contraction-induced vagal reflex 15, 20 . Our data, which is consistent with previous studies 3, 4 , supports the hypothesis that the activation of vagal C fibers by Bam8-22 may lead to the sensitization of the vagal afferent-brainstem-parasympathetic reflex pathway and enhance airway responsiveness.
In summary, we demonstrated that MrgprC11 + jugular sensory neurons, constituting only 2% of vagal sensory neurons, mediate cholinergic bronchoconstriction and play a role in the development of airway hyper-responsiveness in mice. Therapeutic approaches targeting this small population will avoid the possible side effects of antagonizing all vagal nociceptors, which play important roles in maintaining the physiological functions of multiple internal organs. Future studies investigating the endogenous agonists of MrgprC11 in the lung, the peripheral and central axonal projections of MrgprC11 + neurons, and the neural circuit in which these neurons reside will further reveal the neural mechanisms of respiratory diseases. The Mrgpr-clusterΔ −/− mice exhibited decreased anaphylactic bronchoconstriction and reduced airway hyper-responsiveness after influenza virus infection. As 12 Mrgpr genes were deleted in the Mrgpr-clusterΔ −/− mice, the phenotypes observed may not be mediated solely by MrgprC11. Whether the other Mrgpr genes are involved in the tested models requires further investigation. 
0051). d, Representative hemotoxylin and eosin (H&E)-stained lung sections showing that WT and Mrgpr-clusterΔ
−/− mice presented similar lung inflammation responses after IAV inoculation. IFV inoculation experiment was repeated independently two times with similar results. Scale bar, 100 μ m. e, Bam8-22 (50 μ L, 10 mg/mL) enhanced the airway responsiveness to methacholine in WT but not in Mrgpr-clusterΔ −/− mice. (WT + PBS, n = 6; WT + Bam8-22, n = 5; KO + PBS, n = 7; KO + Bam8-22, n = 5; WT + PBS vs. WT + Bam8-22, P = 0.043; WT + Bam8-22 vs. KO + Bam8-22, P = 0.036). f, Vagotomy blocked Bam8-22-induced enhancement of airway responsiveness. (WT + PBS, n = 6; WT + Bam8-22, n = 5; P = 0.79). *P < 0.05, **P < 0.01, ***P < 0.005; two-tailed unpaired Student's t test. Data are presented as mean ± s.e.m.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0074-8.
Head-out whole-body plethysmography. Head-out whole-body plethysmography was performed with anesthetized and spontaneously breathing mice. Mice were anesthetized with urethane and tracheotomized to allow the aspiration of chemicals (2 μ L; 1 mM capsaicin, 1 mM MCh, 5 mM Bam8-22) directly into the trachea through the cannula. Delivering chemicals directly into the trachea allowed us to avoid interference from the upper respiratory tract, which is mainly innervated by trigeminal sensory neurons. The body of the animal was kept in the plethysmography chamber, and respiratory effort was monitored digitally using a Biopac data acquisition system. The respiratory rate and the amplitude of the respiratory waveform were analyzed offline with AcqKnowledge software.
Airway mechanics. Anesthetized (pentobarbital, 70 mg/kg) animals were tracheotomized, attached to a Flexivent pulmonary mechanics analyzer (SCIREQ) and paralyzed with succinylcholine (2 mg/kg). Anesthetized mice were ventilated at a tidal volume of 9 mL/kg, at a frequency of 150 bpm. Anesthetized guinea pigs were ventilated at a tidal volume of 8 mL/kg, at a frequency of 90 bpm. Positive end-expiratory pressure was set at 3 cm H 2 O. We assessed theairway responsiveness using a single-compartment model to measure the total lung resistance (R L ), a dynamic variable that is largely dependent on the resistance to airflow through the airways and sensitive to airway smooth muscle contraction. Bam8-22 (50 μ L, 10 mg/mL for mice; 400 μ L, 20 mg/mL for guinea pigs), NPFF (50 μ L, 10 mg/mL), and MCh (50 μ L, 30 μ g/mL) were administered by retro-orbital i.v. injection. Airway hyper-responsiveness was determined in response to aerosolized methacholine challenges (0, 1, 3, 10 and 30 mg/mL). The nebulizer was on for 10 s to deliver each dose of MCh.
Organ bath studies. Organ bath studies were performed as previously described 23 . Briefly, whole tracheas were dissected out from mice after they were killed, and placed in oxygenated Krebs-bicarbonate solution containing (in mM): 118 NaCl, 5.4 KCl, 1 NaH 2 PO 4 , 1.2 MgSO 4 ,1.9 CaCl2, 25 NaHCO 3 , 11.1 dextrose. Tracheas were cleaned of connective tissue and tracheal rings (whole or laterally divided in half), suspended between two tungsten stirrups in 10-mL organ chambers filled with Krebs solution that was warmed to 37 °C and bubbled with 95% O2-5% CO2 to maintain a pH of 7.4. One stirrup was connected to a strain gauge (model FT03; Grass Instruments, Quincy, MA, USA), and tension was recorded on a Grass Model 7 polygraph (Grass Instruments). Preparations were stretched to a resting tension of 0.2 g and washed with fresh Krebs buffer at 15-min intervals during a 60-min equilibration period. After equilibration, tracheas were challenged with either Bam8-22 (10 μ M) or electrical field stimulation (12 V, 8 Hz, 0.5 ms, 10 s/100 s). At the end of each experiment, all tracheas were maximally contracted with carbamylcholine (1 mM). The results are expressed as a percentage of maximum contraction.
IAV infection-induced lung inflammation. Mouse-adapted influenza A/California/4/2009 H1N1 was a kind gift from S. Klein at the Department of Molecular Microbiology and Immunology at Johns Hopkins University School of Public Health. Eight-to 12-week old mice were anesthetized with ketamine (100 mg/kg) and xylazine (15 mg/kg) and were infected intranasally with 0.4 50% mouse-lethal dose (MLD50) of IAV in 30 μ L of DMEM. Mice in the control group were infected with 30 µ L DMEM medium only. At 5 d postinfection, airway mechanics were examined using the Flexivent system, and bronchoalveolar lavage fluid (BALF) was collected to evaluate lung inflammation. BALF was centrifuged, and the cell pellet was resuspended in PBS to perform differential cell counting of leukocytes (macrophages/monocytes, neutrophils, eosinophils and lymphocytes). The supernatant of BALF was used to examine the levels of TNF-a, IFN-g and IL-6 using enzyme immunoassay kits purchased from R&D Systems (Minneapolis, MN) according to individual kit instructions. Lungs were inflated and fixed with formalin at a pressure of 30 cm H 2 O, and lung sections were processed and stained with hematoxylin and eosin.
Mouse model of anaphylaxis. Mice were sensitized with 20 μ g of OVA emulsified with 2 mg of Imject Alum Adjuvant in 150 μ L PBS by i.p. injection. Twenty-one days after OVA sensitization, mice were anesthetized and challenged with 500 µ g of OVA in 50 μ L of PBS, and airway mechanics were measured using the Flexivent system. The airway resistance increased gradually after the OVA injection, reaching a peak 50-60 s after the injection. To examine the level of OVA-specific IgE, sera of sensitized mice was collected on day 18 (before challenge). The OVA-specific IgE level was determined using the anti-ovalbumin IgE (mouse) ELISA kit (Cayman Chemical, 500840) following the manufacturer's instructions.
House dust mite-induced airway allergic inflammation. Mice were sensitized by i.p. injection of 100 μ g house dust mite extract in 150 μ L PBS on days 1 and 14. Lightly anesthetized mice (isoflurane) were challenged by intranasal instillation of 100 μ g house dust mite extract in 20 μ L PBS on days 18 and 21. Airway mechanics measurements were performed on day 23.
Data analysis and statistics. Statistical analyses were performed using Prism 7 (GraphPad). We did not use statistical methods to predetermine the sample size, but our sample sizes are comparable to those reported in previous publications. Differences between experimental groups were analyzed with two-tailed unpaired Student's t tests. Threshold for significance (α ) was set at 0.05. Data are reported as mean ± s.e.m.. Normality and equality of variance were analyzed with the Shapiro-Wilk normality test and F-test, respectively. When the sample sizes were too small to calculate normality, the distribution was assumed to be normal. The experimenters were blinded to the genotype of the animals. Animals were assigned randomly to the various experimental groups, and data were collected and processed randomly. N values are indicated for all experiments that required statistical analysis. RT-PCR and immunostaining were performed at least three times each with three different animals. Retrograde tracings were performed three times each using three animals each time.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability.
The authors declare that all data generated or analyzed during this study are included within the article and its supplementary information files. We did not use statistical methods to predetermine the sample size. Our sample sizes are comparable to those reported in previous publications. All detail were described in the "Data analysis and statistics." in Methods section.
Data exclusions
Describe any data exclusions.
No data were excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
The number of experiments are stated in the Methods section. RT-PCR and immunostaining were performed at least three times with three different animals.
Retrograde tracings were performed three times using three animals each time. All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
animals were randomly chosen for each experimental group. See "Data analysis and statistics." in Methods.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The experimenter was blind to the genotype of the animals. See "Data analysis and statistics." in Methods.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Describe the software used to analyze the data in this study.
Prism 7 (GraphPad), pCLAMP 9.2 (Axon Instruments), and AcqKnowledge.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There is no restriction on availability of unique materials in this study.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). ICLAC record indicate that HEK cell line might be contaminated with Hela cells. In our study, HEK293 cells were used as a in vitro system to express 12 different Mrgpr family members in mammalian cells. We used this gene expression system combined with calcium imaging assay to test whether these 12 receptors can be activated by peptide Bam8-22. Hela cells can also be used for the same experiments. The possible contamination of Hela cells in our system does not affect our conclusion.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
All mice used are C57Bl/6J. 3 weeks old male animals were used for Ca2+ imaging assay. 2-3 months old males were used for all other experiments. 200-250 grams male Hartley Guinea pigs were purchased from Charles River.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
The study does not involve human research participants.
